259 related articles for article (PubMed ID: 35409036)
1. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409036
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
3. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
4. Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis.
Zawawi A; Naser AY; Alwafi H; Minshawi F
Front Immunol; 2021; 12():666223. PubMed ID: 34046036
[TBL] [Abstract][Full Text] [Related]
5. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
[TBL] [Abstract][Full Text] [Related]
6. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
Oliviero A; de Castro F; Coperchini F; Chiovato L; Rotondi M
Neuroscientist; 2021 Jun; 27(3):214-221. PubMed ID: 32659199
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
10. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic insights into SARS-CoV-2 spike protein induction of the chemokine CXCL10.
Ghazanfari D; Courreges MC; Belinski LE; Hogrell MJ; Lloyd J; C Bergmeier S; McCall KD; Goetz DJ
Sci Rep; 2024 May; 14(1):11179. PubMed ID: 38750069
[TBL] [Abstract][Full Text] [Related]
12. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
Blot M; Jacquier M; Aho Glele LS; Beltramo G; Nguyen M; Bonniaud P; Prin S; Andreu P; Bouhemad B; Bour JB; Binquet C; Piroth L; Pais de Barros JP; Masson D; Quenot JP; Charles PE;
Crit Care; 2020 Nov; 24(1):632. PubMed ID: 33138839
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
Pum A; Ennemoser M; Adage T; Kungl AJ
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
[TBL] [Abstract][Full Text] [Related]
15. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
16. Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease.
Singh H; Singh A; Khan AA; Gupta V
Microb Pathog; 2021 Sep; 158():105023. PubMed ID: 34090983
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the role of chemokines and chemokine receptors involved in coronavirus infection.
Olivarria G; Lane TE
Expert Rev Clin Immunol; 2022 Jan; 18(1):57-66. PubMed ID: 34964406
[TBL] [Abstract][Full Text] [Related]
18. Immune Profiling of COVID-19 in Correlation with SARS and MERS.
Khalil BA; Shakartalla SB; Goel S; Madkhana B; Halwani R; Maghazachi AA; AlSafar H; Al-Omari B; Al Bataineh MT
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062368
[TBL] [Abstract][Full Text] [Related]
19. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Mahmoud IS; Jarrar YB; Febrimarsa
Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574
[TBL] [Abstract][Full Text] [Related]
20. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]